WuXi AppTec Co., Ltd. — Regulatory Filings 2022

Jul 11, 2022

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [147 x 38] intentionally omitted <==

WUXI APPTEC CO., LTD.[*] 無錫藥明康德新藥開發股份有限公司

(A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 2359)

POSITIVE PROFIT ALERT

This announcement is published by the Company simultaneously on the Shanghai Stock Exchange pursuant to the Rules Governing the Listing of Stocks on Shanghai Stock Exchange and on The Stock Exchange of Hong Kong Limited pursuant to the disclosure obligations under Rule 13.09(2)(a) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). The Board hereby announces that the Company is expecting to record an increase in the revenue and net profit attributable to shareholders of the Company for the six months ended June 30, 2022 in comparison with the corresponding period in the year of 2021.

Shareholders and potential investors are advised to exercise caution when dealing in the securities of the Company .

This announcement is published by WuXi AppTec Co., Ltd.* (無錫藥明康德新藥開發股 份有限公司) (the “ Company ”) simultaneously on the Shanghai Stock Exchange pursuant to the Rules Governing the Listing of Stocks on Shanghai Stock Exchange and on The Stock Exchange of Hong Kong Limited pursuant to the disclosure obligations under Rule 13.09(2) (a) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). The board of directors of the Company (the “ Board ”) hereby announces that the Company (together with its subsidiaries, the “ Group ”) is expecting to record an increase in the revenue and net profit attributable to shareholders of the Company for the six months ended June 30, 2022 in comparison with the corresponding period in the year of 2021.

– 1 –

Important Notice:

1. The revenue of the Company was estimated to be approximately RMB17,756.2580 million for the first half of 2022, representing a year-over-year increase of approximately 68.52% compared with RMB10,536.5579 million for the first half of 2021.

2. The revenue of the Company for the second quarter of 2022 was estimated to record a year-over-year increase of approximately 66.16%, which is higher than the estimated 63% to 65% revenue increase for the second quarter of 2022 as disclosed in the announcement of the Company dated June 5, 2022.

3. The net profit attributable to shareholders of the Company was estimated to be approximately RMB4,635.7493 million for the first half of 2022, representing a year-over-year increase of approximately 73.29% compared with RMB2,675.1006 million for the first half of 2021, and the basic earnings per share is estimated to be approximately RMB1.59 for the first half of 2022, representing a year-over-year increase of approximately 72.83% compared with RMB0.92 for the first half of 2021.

4. The net profit attributable to shareholders of the Company after deducting the nonrecurring profit or loss was estimated to be approximately RMB3,849.9678 million for the first half of 2022, representing a year-over-year increase of approximately 81.00% compared with RMB2,127.1046 million for the first half of 2021.

5. The adjusted non-IFRS net profit attributable to shareholders of the Company was estimated to be approximately RMB4,300.6997 million for the first half of 2022, representing a year-over-year increase of approximately 75.68% compared with RMB2,447.9797 million for the first half of 2021.

I. ESTIMATED RESULTS FOR THE CURRENT PERIOD

(1) Period to which the estimated results apply

January 1, 2022 to June 30, 2022.

(2) Estimated Results

1. Based on the preliminary calculation by the finance department of the Company, the revenue of the Company was estimated to be approximately RMB17,756.2580 million for the first half of 2022, representing a year-overyear increase of approximately 68.52% compared with RMB10,536.5579 million for the first half of 2021.

– 2 –

1. The revenue of the Company for the second quarter of 2022 was estimated to record a year-over-year increase of approximately 66.16%, which is higher than the estimated 63% to 65% revenue increase for the second quarter of 2022 as disclosed in the announcement of the Company dated June 5, 2022.

2. The net profit attributable to shareholders of the Company was estimated to be approximately RMB4,635.7493 million for the first half of 2022, representing a year-over-year increase of approximately 73.29% compared with RMB2,675.1006 million for the first half of 2021, and the basic earnings per share is estimated to be approximately RMB1.59 for the first half of 2022, representing a year-over-year increase of approximately 72.83% compared with RMB0.92 for the first half of 2021.

3. The net profit attributable to shareholders of the Company after deducting the non-recurring profit or loss was estimated to be approximately RMB3,849.9678 million for the first half of 2022, representing a year-overyear increase of approximately 81.00% compared with RMB2,127.1046 million for the first half of 2021.

4. The adjusted non-IFRS net profit attributable to shareholders of the Company was estimated to be approximately RMB4,300.6997 million for the first half of 2022, representing a year-over-year increase of approximately 75.68% compared with RMB2,447.9797 million for the first half of 2021.

• (3) The estimated operating results have not been audited by a certified public accountant.

II. RESULTS OF THE CORRESPONDING PERIOD IN THE YEAR OF 2021

• (1) Revenue of the Company: RMB10,536.5579 million. Net profit attributable to the shareholders of the Company: RMB2,675.1006 million. Net profit attributable to the shareholders of the Company after deducting the non-recurring profit or loss: RMB2,127.1046 million.

• (2) Basic earnings per share: RMB0.92.

– 3 –

III. MAIN REASONS FOR THE ESTIMATED GROWTH IN RESULTS FOR THE CURRENT PERIOD

1. The revenue of the Company for the first half of 2022 was estimated to record a year-over-year increase of approximately 68.52%. The revenue of the Company for the second quarter of 2022 was estimated to record a year-over-year increase of approximately 66.16%, which is higher than the estimated 63% to 65% revenue increase of the second quarter of 2022 as disclosed in the announcement of the Company dated June 5, 2022. The Company continued to strengthen its unique integrated Contract Research Development and Manufacturing Organization (CRDMO) and Contract Testing Development and Manufacturing Organization (CTDMO) business models. While adhering to COVID-19 pandemic prevention and control measures in Shanghai, the Company also swiftly formulated and effectively implemented its business continuity plan, fully capitalizing on its global capacity, multiple operational locations and comprehensive coverage across industry supply chains, which ensured the achievement of the Company’s overall performance targets.

2. The net profit attributable to shareholders of the Company for the first half of 2022 was estimated to record a year-over-year increase of approximately 73.29%, and the basic earnings per share for the first half of 2022 was estimated to record a year-over-year increase of approximately 72.83%, both outpaced the revenue growth in the same period. The Company maintains its strong growth in revenue while continuing to improve the efficiency of its operations and management.

3. The net profit attributable to shareholders of the Company after deducting the non-recurring profit or loss for the first half of 2022 was estimated to record a year-over-year increase of approximately 81.00%. Main effect of the non-recurring profit or loss items on profit for the first half of 2022 primarily include: fair value changes in and investment gains of the investment portfolios were estimated to be approximately RMB448.6253 million, representing a year-over-year decrease of approximately RMB1,600.1376 million compared with RMB2,048.7629 million for the first half of 2021; however, the changes in fair value of the non-cash carrying amount of the derivative component of H share convertible bonds of the Company for the first half of 2022 were estimated to be a net gain of approximately RMB274.5090 million, representing a turn-around of approximately RMB1,767.8488 million as compared to the net loss of RMB1,493.3398 million in the first half of 2021.

– 4 –

1. The adjusted non-IFRS net profit attributable to shareholders of the Company for the first half of 2022 was estimated to record a year-over-year increase of approximately 75.68%. The Company further raised its production utilization rate and substantially improved its economy of scale through continuous optimization of operating efficiency. The increases in adjusted non-IFRS net profit attributable to shareholders of the Company for the first half of 2022 outpaced the increase in revenue in the same period. The Company believes that the adjusted financial measures are useful for understanding and assessing its business performance and operation trends.

IV. RISK WARNING

There are no significant uncertainties pertaining to the Company identified as at the date of this announcement which may affect the accuracy of the estimated results.

V. OTHER INFORMATION

The Board would like to remind the investors that the above estimated results of the Company for the six months ended June 30, 2022 were prepared based on preliminary accounting information only. Please refer to the announcement of the unaudited 2022 interim results of the Company to be published subsequently for the finalized financial figures. Investors are advised to pay attention to the investment risks.

Shareholders and potential investors are advised to exercise caution when dealing in the securities of the Company.

By order of the Board WuXi AppTec Co., Ltd. Dr. Ge Li* Chairman

Hong Kong, July 11, 2022

As at the date of this announcement, the Board comprises Dr. Ge Li, Mr. Edward Hu, Dr. Steve Qing Yang, Dr. Minzhang Chen, Mr. Zhaohui Zhang and Dr. Ning Zhao as executive Directors, Mr. Xiaomeng Tong and Dr. Yibing Wu as non-executive Directors and Dr. Jiangnan Cai, Ms. Yan Liu, Dr. Hetong Lou, Mr. Xiaotong Zhang and Mr. Dai Feng as independent non-executive Directors.

• For identification purposes only

– 5 –